Online Message
Jiuzhitang Yonghe Qihang Fund initiated by Jiuzhitang forged partnership with Stemedica Cell Technologies, Inc. in 2018 by investing in the company, and founded Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. as the sole China recipient of stem cell technologies developed by Stemedica. By introducing Stemedica’s state-of-the-art stem cell manufacturing technologies and platform into China, Jiuzhitang Maker will realize a high level of stem cell expansion and address those key technical issues involved in making stem cells into drugs.
Copyright: Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Business License
